Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017

Background: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life-years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, for 359 diseases and injuries for 195 countries and territories over the past 28 years. Methods: We used data for age-specific mortality rates, years of life lost (YLLs) due to premature mortality, and years lived with disability (YLDs) from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to calculate HALE and DALYs from 1990 to 2017. We calculated HALE using age-specific mortality rates and YLDs per capita for each location, age, sex, and year. We calculated DALYs for 359 causes as the sum of YLLs and YLDs. We assessed how observed HALE and DALYs differed by country and sex from expected trends based on Socio-demographic Index (SDI). We also analysed HALE by decomposing years of life gained into years spent in good health and in poor health, between 1990 and 2017, and extra years lived by females compared with males. Findings: Globally, from 1990 to 2017, life expectancy at birth increased by 7\ub74 years (95% uncertainty interval 7\ub71\u20137\ub78), from 65\ub76 years (65\ub73\u201365\ub78) in 1990 to 73\ub70 years (72\ub77\u201373\ub73) in 2017. The increase in years of life varied from 5\ub71 years (5\ub70\u20135\ub73) in high SDI countries to 12\ub70 years (11\ub73\u201312\ub78) in low SDI countries. Of the additional years of life expected at birth, 26\ub73% (20\ub71\u201333\ub71) were expected to be spent in poor health in high SDI countries compared with 11\ub77% (8\ub78\u201315\ub71) in low-middle SDI countries. HALE at birth increased by 6\ub73 years (5\ub79\u20136\ub77), from 57\ub70 years (54\ub76\u201359\ub71) in 1990 to 63\ub73 years (60\ub75\u201365\ub77) in 2017. The increase varied from 3\ub78 years (3\ub74\u20134\ub71) in high SDI countries to 10\ub75 years (9\ub78\u201311\ub72) in low SDI countries. Even larger variations in HALE than these were observed between countries, ranging from 1\ub70 year (0\ub74\u20131\ub77) in Saint Vincent and the Grenadines (62\ub74 years [59\ub79\u201364\ub77] in 1990 to 63\ub75 years [60\ub79\u201365\ub78] in 2017) to 23\ub77 years (21\ub79\u201325\ub76) in Eritrea (30\ub77 years [28\ub79\u201332\ub72] in 1990 to 54\ub74 years [51\ub75\u201357\ub71] in 2017). In most countries, the increase in HALE was smaller than the increase in overall life expectancy, indicating more years lived in poor health. In 180 of 195 countries and territories, females were expected to live longer than males in 2017, with extra years lived varying from 1\ub74 years (0\ub76\u20132\ub73) in Algeria to 11\ub79 years (10\ub79\u201312\ub79) in Ukraine. Of the extra years gained, the proportion spent in poor health varied largely across countries, with less than 20% of additional years spent in poor health in Bosnia and Herzegovina, Burundi, and Slovakia, whereas in Bahrain all the extra years were spent in poor health. In 2017, the highest estimate of HALE at birth was in Singapore for both females (75\ub78 years [72\ub74\u201378\ub77]) and males (72\ub76 years [69\ub78\u201375\ub70]) and the lowest estimates were in Central African Republic (47\ub70 years [43\ub77\u201350\ub72] for females and 42\ub78 years [40\ub71\u201345\ub76] for males). Globally, in 2017, the five leading causes of DALYs were neonatal disorders, ischaemic heart disease, stroke, lower respiratory infections, and chronic obstructive pulmonary disease. Between 1990 and 2017, age-standardised DALY rates decreased by 41\ub73% (38\ub78\u201343\ub75) for communicable diseases and by 49\ub78% (47\ub79\u201351\ub76) for neonatal disorders. For non-communicable diseases, global DALYs increased by 40\ub71% (36\ub78\u201343\ub70), although age-standardised DALY rates decreased by 18\ub71% (16\ub70\u201320\ub72). Interpretation: With increasing life expectancy in most countries, the question of whether the additional years of life gained are spent in good health or poor health has been increasingly relevant because of the potential policy implications, such as health-care provisions and extending retirement ages. In some locations, a large proportion of those additional years are spent in poor health. Large inequalities in HALE and disease burden exist across countries in different SDI quintiles and between sexes. The burden of disabling conditions has serious implications for health system planning and health-related expenditures. Despite the progress made in reducing the burden of communicable diseases and neonatal disorders in low SDI countries, the speed of this progress could be increased by scaling up proven interventions. The global trends among non-communicable diseases indicate that more effort is needed to maximise HALE, such as risk prevention and attention to upstream determinants of health. Funding: Bill & Melinda Gates Foundation